Post-labeling stabilization of radiolabeled proteins and peptides
US6066309A · kind A · utility
25Cited by
17References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 1997 |
| Grant date | May 23, 2000 |
| Priority date | — |
| Expiry date | Feb 3, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/863
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention relates to the use of ascorbic acid and derivatives thereof in stabilizing radiolabeled proteins and peptides against oxidation loss of radiolabel and autoradiolysis. Ascorbic acid is added after radiolabeling, including any required incubation period, but prior to patient administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.